Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Outcome already public

Rules 1.1.0 · as of 14 Sep 2026

Rick Doblin · Said 3 Feb 2023 · doblin-0188

Quote

Outcome already public

“Australians who have endured long-standing psychological suffering will soon have the opportunity to consider emerging treatments backed by rigorous clinical research: MDMA-assisted therapy for PTSD, with two successful Phase 3 studies, and psilocybin-assisted therapy for treatment-resistant depression, currently in Phase 2 clinical trials.”
· Statement: Psychedelic-Assisted Therapies Allowed in Australia Through Special Access Scheme · article

MAPS statement on Australia's TGA decision to allow psychiatrists to prescribe MDMA for PTSD and psilocybin for treatment-resistant depression from July 2023. Doblin predicts Australians will soon be able to access these treatments.

The outcome had been publicly determined or announced by the deciding body or sponsor on the statement date.

← Earlier · Later → · All statements